Lenamilast

N/A

Report date: 2025/06/05 14:30:36
NME

Base Information

Drug NameLenamilast
Drug Alias NameITG-1052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Intragrand Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Intragrand Pharma Co LtdTranspire Bio Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A